Jefferies downgraded Pactiv Evergreen (PTVE) to Hold from Buy with a price target of $18, up from $15. The firm cites the sale to Novolex for the downgrade and views the regulatory risk as manageable.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTVE: